$ATRS ANTARES PHARMA, INC. Insider Trading Week 24/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. in week 24/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2015 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.18 | 99,395 | 216,681 | 99,395 | |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 1,447 | 3,589 | 7,320,109 | 7.3 M to 7.3 M (-0.02 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 1,842 | 4,568 | 9,316,502 | 9.3 M to 9.3 M (-0.02 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 611 | 1,515 | 3,715,311 | 3.7 M to 3.7 M (-0.02 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 76,728 | 189,948 | 7,321,556 | 7.4 M to 7.3 M (-1.04 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 97,654 | 241,752 | 9,318,344 | 9.4 M to 9.3 M (-1.04 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 32,419 | 80,256 | 3,715,922 | 3.7 M to 3.7 M (-0.86 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 19,889 | 47,839 | 7,398,284 | 7.4 M to 7.4 M (-0.27 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 25,313 | 60,885 | 9,415,998 | 9.4 M to 9.4 M (-0.27 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 8,403 | 20,212 | 3,748,341 | 3.8 M to 3.7 M (-0.22 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 43,506 | 104,506 | 7,418,173 | 7.5 M to 7.4 M (-0.58 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 55,372 | 133,009 | 9,441,311 | 9.5 M to 9.4 M (-0.58 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 18,382 | 44,155 | 3,756,744 | 3.8 M to 3.8 M (-0.49 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 35,915 | 86,322 | 7,461,679 | 7.5 M to 7.5 M (-0.48 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 45,710 | 109,864 | 9,496,683 | 9.5 M to 9.5 M (-0.48 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 15,175 | 36,473 | 3,775,126 | 3.8 M to 3.8 M (-0.40 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 22,973 | 55,144 | 3,790,301 | 3.8 M to 3.8 M (-0.60 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 5,267 | 12,641 | 3,813,274 | 3.8 M to 3.8 M (-0.14 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 1,568 | 3,771 | 3,818,541 | 3.8 M to 3.8 M (-0.04 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 54,370 | 130,510 | 7,497,594 | 7.6 M to 7.5 M (-0.72 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 69,198 | 166,103 | 9,542,393 | 9.6 M to 9.5 M (-0.72 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 12,467 | 29,921 | 7,551,964 | 7.6 M to 7.6 M (-0.16 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 15,866 | 38,078 | 9,611,591 | 9.6 M to 9.6 M (-0.16 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 3,710 | 8,923 | 7,564,431 | 7.6 M to 7.6 M (-0.05 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 4,722 | 11,356 | 9,627,457 | 9.6 M to 9.6 M (-0.05 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 44,010 | 106,874 | 7,568,141 | 7.6 M to 7.6 M (-0.58 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 56,012 | 136,020 | 9,632,179 | 9.7 M to 9.6 M (-0.58 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 18,551 | 44,986 | 7,612,151 | 7.6 M to 7.6 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 23,611 | 57,257 | 9,688,191 | 9.7 M to 9.7 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 18,551 | 44,986 | 7,630,702 | 7.6 M to 7.6 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 23,611 | 57,257 | 9,711,802 | 9.7 M to 9.7 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 18,595 | 45,156 | 3,820,109 | 3.8 M to 3.8 M (-0.48 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 7,838 | 19,007 | 3,838,704 | 3.8 M to 3.8 M (-0.20 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 7,838 | 19,007 | 3,846,542 | 3.9 M to 3.8 M (-0.20 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.47 | 67,627 | 166,782 | 7,649,253 | 7.7 M to 7.6 M (-0.88 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.47 | 86,071 | 212,268 | 9,735,413 | 9.8 M to 9.7 M (-0.88 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 58,251 | 144,445 | 7,716,880 | 7.8 M to 7.7 M (-0.75 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 74,137 | 183,838 | 9,821,484 | 9.9 M to 9.8 M (-0.75 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.47 | 28,574 | 70,469 | 3,854,380 | 3.9 M to 3.9 M (-0.74 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 24,612 | 61,030 | 3,882,954 | 3.9 M to 3.9 M (-0.63 %) |